Advertisement
Screener

Foghorn Therapeutics Inc. (FHTX) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

2.2 / 5 stars · 26/59 Roast Me

Foghorn Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

Foghorn Therapeutics Inc. (FHTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value of $4.80 million for the 12-month period ending 2020-12-31, per its 10-K/A filed 2022-08-09.

Discontinued › Notes

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue · last filed 2022-08-09

  • Foghorn Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for fiscal 2020 was $4.80M, a 45.45% increase from fiscal 2019.
  • Foghorn Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for fiscal 2019 was $3.30M.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 12 month
2020-12-31$4.80M
10-K/A · filed 2022-08-09
2019-12-31$3.30M
10-K · filed 2021-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Nkarta, Inc. (NKTX)United States$0.205B-1.73
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37